BTR hits high-grade gold at Second Fortune
Infill and extensional drilling has confirmed the consistency of the narrow-vein, high-grade gold at Brightstar Resources’ Second Fortune mine
Stockhead
Long Shortz with Caprice Resources
Stockhead’s Fraser Palamara is joined by Caprice Resources CEO Luke Cox, live from the company’s Island Gold project.
Javelin drills high-grade gold, copper
Javelin Minerals’ maiden drilling at its Coogee project has proven extensions to mineralisation with high-grade intersections.
Tony’s Takeaway: Discovery doppelgangers
Tony Locantro puts his focus on the explorers honing in on big-time targets presenting in the fashion of some great discoveries.
More Stories
SPR targets more gold for Dalgaranga restart
Spartan is looking to update resource confidence and add more ounces at the Dalgaranga gold project in WA.
Opthea could triple if phase III succeeds: Canaccord
Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial succeeds.
ASX biotechs hitting critical trial stage
Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory approval.
Canterbury jumps on copper discovery
Drilling at Alma Metals and Canterbury Resources’ Briggs asset in QLD uncovered near surface, high-grade copper and molybdenum mineralisation.
ASX hits record; Karoon jumps 8pc on buyback
ASX hits record high on rate cut hopes, energy stocks up as Karoon rallies and SoftBank eyes $25bn stake in OpenAI.
WYX places focus on bauxite
Western Yilgarn starts resource estimation work to confirm Julimar West as an advanced, strategically located bauxite project.
Tony’s Takeaway: Replicating rewards
Tony Locantro looks at a couple of ASX-listers showing some similarity upside when compared to much larger companies.
Airtasker posts another quarter of positive free cash flow
Airtasker has grown its positive free cash flow to $500,000 in Q2 FY25 with operating cash flow of $1m, up 40.0% on pcp.
Milestones hit by ASX health stocks
We run the ruler over ASX health stock quarterlies, with Bioxyne achieving record Q2 FY25 trading revenue.
ASX up as Fed stalls; Alibaba rattles Nvidia
ASX rises despite Wall Street dip, Alibaba’s AI shakes Nvidia, Lovisa hit with class action and IGO posts quarterly earnings loss.
Original URL: https://www.themercury.com.au/business/stockhead/page/20